KAYIKÇIOGLU, E.; FINDOS, E. The prognostic immune nutritional index is a predictive biomarker in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide: Prognostic immune nutritional index and prostate adenocancer. The Injector, [S. l.], v. 1, n. 3, p. 106–114, 2022. DOI: 10.5281/zenodo.7331456. Disponível em: https://injectormedicaljournal.com/index.php/theinjector/article/view/56. Acesso em: 17 jul. 2024.